老年套细胞淋巴瘤患者的临床特征与预后因素分析
回顾性分析11个中心255例老年套细胞淋巴瘤(MCL)患者,中位年龄69岁,3年总生存率42.0%、无进展生存率21.2%。多因素分析显示高龄、高LDH、骨髓受累、Ann Arbor分期Ⅲ~Ⅳ期与不良PFS相关,高龄和高LDH与不良OS相关;老年综合评估提示肾功能不全与较差OS相关。
要点
- 老年MCL患者占全部MCL的32.1%,男性居多(78.4%),初诊多为晚期(88.6%)。
- 高龄(≥80岁)和高LDH水平为OS的独立预后不良因素。
- 高龄、Ann Arbor分期Ⅲ~Ⅳ期、高LDH、骨髓受累为PFS的独立预后不良因素。
核心结论
- 老年MCL患者合并基础疾病更多。
- 高龄、高LDH水平、肾功能不全、骨髓受累、Ann Arbor分期Ⅲ~Ⅳ期为老年MCL患者预后的独立危险因素。
研究设计与样本
- 回顾性分析2000年1月至2021年2月北京大学第三医院等11个中心收治的255例老年(≥65岁)MCL患者的临床资料。
- 对50例有白蛋白水平及基础疾病资料的老年MCL患者进行老年综合疾病评估。
- 采用Kaplan-Meier法和Cox回归模型进行预后的单因素及多因素分析。
主要发现
- 795例MCL患者中老年患者255例(32.1%),男性78.4%,中位年龄69(65~88)岁,初诊晚期占88.6%。
- 治疗总有效率77.3%,完全缓解率33.3%,3年OS率42.0%,3年PFS率21.2%。
- 老年MCL患者相较年轻患者更易合并高血压等慢性基础疾病。
- 多因素分析:与PFS相关的独立预后不良因素包括高龄(P=0.021)、Ann Arbor分期Ⅲ~Ⅳ期(P=0.003)、高LDH水平(P=0.003)、骨髓受累(P=0.014)。
- 与OS相关的独立预后不良因素包括高龄(P=0.001)、高LDH水平(P=0.003);老年综合疾病评估提示肾功能不全为与OS相关的预后不良因素(P=0.047)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To examine the clinical characteristics and prognostic factors of elderly patients with mantle cell lymphoma (MCL) and the impact of nutrition and underlying diseases on the prognosis of elderly patients with MCL. Methods: retrospectively analyzed 255 elderly patients with MCL from 11 medical centers, including Peking University Third Hospital between January 2000 and February 2021. We analyzed clinical data, such as age, gender, Mantle Cell Lymphoma International Prognostic Index score, and treatment options, and performed univariate and multivariate prognostic analysis. We performed a comprehensive geriatric assessment on elderly MCL patients with medical records that included retraceable underlying disease and albumin levels, and we investigated the impact of basic nutrition and underlying disorders on MCL prognosis in the elderly. Results: There were 255 senior individuals among the 795 MCL patients. Elderly MCL was more common in males (78.4%), with a median age of 69 yr (ages 65-88), and the majority (88.6%) were identified at a late stage. The 3-yr overall survival (OS) rate was 42.0%, with a 21.2% progression-free survival (PFS) rate. The overall response rate (ORR) was 77.3%, with a 33.3% total remission rate. Elderly patients were more likely than younger patients to have persistent underlying illnesses, such as hypertension. Multivariate analysis revealed that variables related with poor PFS included age of ≥80 (P=0.021), Ann Arbor stage Ⅲ-Ⅳ (P=0.003), high LDH level (P=0.003), involvement of bone marrow (P=0.014). Age of ≥80 (P=0.001) and a high LDH level (P=0.003) were risk factors for OS. The complete geriatric assessment revealed that renal deficiency was associated with poorer OS (P=0.047) . Conclusions: Elderly MCL patients had greater comorbidities. Age, LDH, renal function, bone marrow involvement, and Ann Arbor stage are all independent risk factors for MCL in the elderly. 目的: 分析老年(≥65岁)套细胞淋巴瘤(MCL)患者的临床特征和预后影响因素,探讨基础营养和疾病状态对老年MCL患者预后的影响。 方法: 回顾性分析2000年1月至2021年2月在北京大学第三医院等11个中心收治的255例老年MCL患者的临床资料,主要指标包括年龄、性别、MIPI评分、治疗方案及疗效,采用Kaplan-Meier法和Cox回归模型进行预后的单因素及多因素分析;对50例有白蛋白水平及基础疾病资料的老年MCL患者进行老年综合疾病评估,分析老年患者基础疾病和基础营养状态,以及老年综合疾病状态对预后的影响。 结果: 在纳入的795例MCL患者中,老年MCL患者255例(32.1%)。老年MCL好发于男性(78.4%),中位年龄69(65~88)岁,初诊时多为晚期(88.6%)。老年MCL患者的治疗总有效率为77.3%,完全缓解率为33.3%。3年总生存(OS)率为42.0%,3年无进展生存(PFS)率为21.2%。老年MCL患者相较年轻患者更易合并高血压等慢性基础疾病。多因素分析结果显示,与PFS期相关的独立预后不良因素包括高龄(P=0.021)、Ann Arbor分期Ⅲ~Ⅳ期(P=0.003)、高LDH水平(P=0.003)、骨髓受累(P=0.014);与OS期相关的独立预后不良因素包括高龄(P=0.001)、高LDH水平(P=0.003)。老年综合疾病评估提示肾功能不全为与OS相关的预后不良因素(P=0.047)。 结论: 老年MCL患者合并基础疾病更多;高龄、高LDH水平、肾功能不全、骨髓受累、Ann Arbor分期Ⅲ~Ⅳ期为老年MCL患者预后的独立危险因素。.
引用
- Hao XY, Yang P, Zhang W, et al. [Clinical features and prognostic factors of elderly patients with mantle cell lymphoma]. Zhonghua Xue Ye Xue Za Zhi. 2023. PMID: 37550206. doi:10.3760/cma.j.issn.0253-2727.2023.06.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。